T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 13 THB -1.52%
Market Cap: ฿5.2B

T Man Pharmaceutical PCL
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

T Man Pharmaceutical PCL
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
T Man Pharmaceutical PCL
SET:TMAN
Revenue
฿2.5B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mega Lifesciences PCL
SET:MEGA
Revenue
฿14.1B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
6%
I
Inter Pharma PCL
SET:IP
Revenue
฿2B
CAGR 3-Years
19%
CAGR 5-Years
39%
CAGR 10-Years
N/A
J
Jack Chia Industries Thailand PCL
SET:JCT
Revenue
฿872.2m
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
0%
J
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
Revenue
฿1B
CAGR 3-Years
33%
CAGR 5-Years
17%
CAGR 10-Years
N/A
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Revenue
฿1.7B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

T Man Pharmaceutical PCL
Glance View

Market Cap
5.2B THB
Industry
N/A

T Man Pharmaceutical PCL is a TH-based company operating in industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-10-22. T.Man Pharmaceutical Public Company Limited is engaged in purchasing, importing, manufacturing, original equipment manufacturing, distributing and exporting of modern medicines, traditional medicine, dietary supplements, and health care products for the healthcare industry with subsidiaries as manufacturers. Its segments include manufactured products under own brand, manufactured products under third parties’ brand and trading products. With a diverse range of manufacturing machinery, it can produce various types of pharmaceutical products, meeting the needs of every consumer. Its production capabilities include tablets, capsules, powders, liquids, and semisolids. The company offers capsule products, including both hard and soft capsules in various sizes, all made with imported, high-quality raw materials. Its product range covers a wide range of diseases and comes in various forms, including uncoated tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, and suppositories.

TMAN Intrinsic Value
19.17 THB
Undervaluation 32%
Intrinsic Value
Price ฿13
T

See Also

What is T Man Pharmaceutical PCL's Revenue?
Revenue
2.5B THB

Based on the financial report for Dec 31, 2025, T Man Pharmaceutical PCL's Revenue amounts to 2.5B THB.

What is T Man Pharmaceutical PCL's Revenue growth rate?
Revenue CAGR 3Y
8%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for T Man Pharmaceutical PCL have been 8% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett